🔎 Trials Near Me

Dachaigh › Aillse Sgamhain Neo-chealla-beag › Illinois › Cicero

Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Cicero, IL

Tha 24 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Cicero (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

A’ fastadhÌre 3
  • Edward Hines Jr VA Hospital, Hines · 4 mìle air falbh
  • Advocate Christ Medical Center, Oak Lawn · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

A’ fastadhÌre 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06498635

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A’ fastadhÌre 3
  • Hope and Healing Cancer Services, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

A’ fastadhÌre 3
  • Advocate Christ Medical Center, Oak Lawn · 9 mìle air falbh
  • Hope and Healing Cancer Services, Hinsdale · 10 mìle air falbh
  • Endeavor Health, Elmhurst · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06758401

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

A’ fastadhÌre 2
  • Hope and Healing Clinical Research, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07489066

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

A’ fastadhÌre 3
  • Research Site, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06357533

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

A’ fastadhÌre 3
  • Affiliated Oncologists, LLC, Chicago Ridge · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06561386

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

A’ fastadhÌre 3
  • Research Site, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06692738

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

A’ fastadhÌre 2/3
  • Loyola University Medical Center, Maywood · 5 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04613596

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

A’ fastadhÌre 3
  • Hope and Healing Cancer Services, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06899126

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

A’ fastadhÌre 3
  • Research Site, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07291037

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

A’ fastadhÌre 3
  • Research Site, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06350097

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

A’ fastadhÌre 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT06686771

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

A’ fastadhÌre 3
  • Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT06216301

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mìle air falbh
  • Edward Hines Jr VA Hospital, Hines · 4 mìle air falbh
  • Loyola University Medical Center, Maywood · 5 mìle air falbh
  • agus 2 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

A’ fastadhSgrùdadh amharc
  • Affiliated Oncologists, LLC, Chicago Ridge · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT05885698

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • Edward Hines Jr VA Hospital, Hines · 4 mìle air falbh
  • Loyola University Medical Center, Maywood · 5 mìle air falbh
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mìle air falbh
  • agus 3 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2/3
  • Loyola University Medical Center, Maywood · 5 mìle air falbh
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mìle air falbh
  • Advocate Christ Medical Center, Oak Lawn · 9 mìle air falbh
  • agus 2 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • Edward Hines Jr VA Hospital, Hines · 4 mìle air falbh
  • Loyola University Medical Center, Maywood · 5 mìle air falbh
  • Northwestern Medicine Oak Brook, Oak Brook · 9 mìle air falbh
18 Minutes · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

A’ fastadhSgrùdadh amharc
  • Advocate Christ Medical Center, Oak Lawn · 9 mìle air falbh
  • Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mìle air falbh
  • Advocate High Tech Medical Park, Palos Heights · 12 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

A’ fastadh
  • Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Gearr 2026 · NCT02984761

GEMINI-NSCLC: NSCLC Biomarker Study

A’ fastadhSgrùdadh amharc
  • Hope and Healing Cancer Services, Hinsdale · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Gearr 2026 · NCT05236114

Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile

Sgrùdaidhean eile ann an Cicero

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.